Composition
Valganciclovir Tablets 450 mg
About VALSIYA
VALSIYA contains valganciclovir, an antiviral prodrug of ganciclovir with activity against cytomegalovirus (CMV). CMV infection is a significant risk after organ transplantation, and valganciclovir is used for its prevention and treatment.
Indications
Prevention and treatment of cytomegalovirus (CMV) disease in solid-organ transplant recipients, under specialist supervision.
Dosage & Administration
As directed by the physician.
Storage
Store below 25°C, protected from light and moisture. Keep out of reach of children.